Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

AVI Starting Avicine Phase III To Speed Approval Timeline

May 3, 2002

AVI BioPharma Inc. changed the course for its lead anticancer product, the vaccine Avicine, in an effort to shorten the route toward a possible FDA approval. (BioWorld Today)

AVI Starting Avicine Phase III To Speed Approval Timeline

May 3, 2002

AVI BioPharma Inc. changed the course for its lead anticancer product, the vaccine Avicine, in an effort to shorten the route toward a possible FDA approval. (BioWorld Today)

Nyxis Getting Ready To Move Glyxins Family Into The Clinic

May 3, 2002

FDA Stops Phase III Enrollment In Dendreon’s Provenge Trial

May 2, 2002

FDA Stops Phase III Enrollment In Dendreon’s Provenge Trial

May 2, 2002

Ribozyme Suffers Setback On Two Leading Drug Candidates

May 1, 2002

Ribozyme Suffers Setback On Two Leading Drug Candidates

May 1, 2002

NeoTherapeutics’ Neotrofin Fails In Phase III Alzheimer’s Study

April 30, 2002

NeoTherapeutics’ Neotrofin Fails In Phase III Alzheimer’s Study

April 30, 2002

Replidyne Raises $13 Million In Series A For Antimicrobials

April 26, 2002

View All Articles by Karen Young